LBP AM’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $624K | Sell |
11,359
-666
| -6% | -$36.6K | 0.01% | 345 |
|
|
2025
Q1 | $850K | Buy |
12,025
+6,576
| +121% | +$465K | 0.01% | 329 |
|
|
2024
Q4 | $358K | Sell |
5,449
-11,237
| -67% | -$739K | ﹤0.01% | 349 |
|
|
2024
Q3 | $1.17M | Buy |
16,686
+5,517
| +49% | +$388K | 0.02% | 282 |
|
|
2024
Q2 | $920K | Buy |
11,169
+1,117
| +11% | +$92K | 0.04% | 264 |
|
|
2024
Q1 | $878K | Sell |
10,052
-225,450
| -96% | -$19.7M | 0.04% | 269 |
|
|
2023
Q4 | $22.7M | Hold |
235,502
| – | – | 0.5% | 52 |
|
|
2023
Q3 | $20.8M | Sell |
235,502
-732
| -0.3% | -$64.8K | 0.46% | 59 |
|
|
2023
Q2 | $20.5M | Buy |
236,234
+11,605
| +5% | +$1.01M | 0.48% | 63 |
|
|
2023
Q1 | $21.8M | Sell |
224,629
-29,544
| -12% | -$2.87M | 0.56% | 59 |
|
|
2022
Q4 | $26.3M | Buy |
+254,173
| New | +$26.3M | 0.75% | 36 |
|